Clinical Trials
3 trialsNCT03817125 2024-06-06
MCGRAW
Parker Institute for Cancer Immunotherapy
Phase 1 Completed
NCT00932152 2017-10-19
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
University of Pittsburgh
Phase 2 Terminated
NCT01931150 2017-01-13
Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT
Memorial Sloan Kettering Cancer Center
Phase 3 Completed